156 related articles for article (PubMed ID: 18767938)
1. New views on immunopotentiators in modern vaccines.
Schijns VE; Brewer JM
Expert Rev Vaccines; 2008 Sep; 7(7):877-9. PubMed ID: 18767938
[TBL] [Abstract][Full Text] [Related]
2. Immunology of vaccine adjuvants.
Ribeiro CM; Schijns VE
Methods Mol Biol; 2010; 626():1-14. PubMed ID: 20099117
[TBL] [Abstract][Full Text] [Related]
3. An overview of adjuvants utilized in prophylactic vaccine formulation as immunomodulators.
Chauhan N; Tiwari S; Iype T; Jain U
Expert Rev Vaccines; 2017 May; 16(5):491-502. PubMed ID: 28285554
[TBL] [Abstract][Full Text] [Related]
4. The Immunotherapeutics and Vaccine Summit - CHI's fifth annual meeting - novel vaccines: adjuvants and delivery systems: part 1.
Jones SD
IDrugs; 2010 Oct; 13(10):689-91. PubMed ID: 20878588
[TBL] [Abstract][Full Text] [Related]
5. Vaccine adjuvants.
Macy DW
Semin Vet Med Surg Small Anim; 1997 Aug; 12(3):206-11. PubMed ID: 9283246
[TBL] [Abstract][Full Text] [Related]
6. Particulate vaccines: on the quest for optimal delivery and immune response.
De Temmerman ML; Rejman J; Demeester J; Irvine DJ; Gander B; De Smedt SC
Drug Discov Today; 2011 Jul; 16(13-14):569-82. PubMed ID: 21570475
[TBL] [Abstract][Full Text] [Related]
7. Liposomes as carrier and immunoadjuvant of vaccine antigens.
van Rooijen N
Adv Biotechnol Processes; 1990; 13():255-79. PubMed ID: 2185785
[No Abstract] [Full Text] [Related]
8. Immunopotentiators in modern vaccines. Proceedings of the second IMV meeting. May 18-20, 2005. Malaga, Spain.
Vaccine; 2006 Jun; 24(26):5391-472. PubMed ID: 17007079
[No Abstract] [Full Text] [Related]
9. 12th Annual Conference on Vaccine Research.
O'Brien J
Expert Rev Vaccines; 2009 Sep; 8(9):1139-42. PubMed ID: 19722886
[TBL] [Abstract][Full Text] [Related]
10. Vaccine immunopotentiators of the future.
Schijns VE; Degen WG
Clin Pharmacol Ther; 2007 Dec; 82(6):750-5. PubMed ID: 17914440
[TBL] [Abstract][Full Text] [Related]
11. Novel adjuvants and delivery systems for enhancing immune responses induced by immunogens.
Dey AK; Srivastava IK
Expert Rev Vaccines; 2011 Feb; 10(2):227-51. PubMed ID: 21105782
[TBL] [Abstract][Full Text] [Related]
12. All things mucosal.
Thanavala Y; Lavelle E; Ogra P
Expert Rev Vaccines; 2009 Feb; 8(2):139-42. PubMed ID: 19196192
[TBL] [Abstract][Full Text] [Related]
13. IABS international scientific workshop--Mode of Action of Adjuvants: implications for vaccine safety and design, April 29-30, 2010, Bethesda, MD, USA.
Seemann S; Dodet B
Vaccine; 2011 Apr; 29(17):3340. PubMed ID: 21335035
[No Abstract] [Full Text] [Related]
14. Chitosan-based systems for the delivery of vaccine antigens.
Arca HC; Günbeyaz M; Senel S
Expert Rev Vaccines; 2009 Jul; 8(7):937-53. PubMed ID: 19538118
[TBL] [Abstract][Full Text] [Related]
15. Mucosal delivery of vaccine antigens and its advantages in pediatrics.
De Magistris MT
Adv Drug Deliv Rev; 2006 Apr; 58(1):52-67. PubMed ID: 16516335
[TBL] [Abstract][Full Text] [Related]
16. Induction and direction of immune responses by vaccine adjuvants.
Schijns VE
Crit Rev Immunol; 2001; 21(1-3):75-85. PubMed ID: 11642615
[TBL] [Abstract][Full Text] [Related]
17. Montanide ISA 720 and 51: a new generation of water in oil emulsions as adjuvants for human vaccines.
Aucouturier J; Dupuis L; Deville S; Ascarateil S; Ganne V
Expert Rev Vaccines; 2002 Jun; 1(1):111-8. PubMed ID: 12908518
[TBL] [Abstract][Full Text] [Related]
18. Next generation vaccines.
Riedmann EM
Hum Vaccin; 2011 Jul; 7(7):718-22. PubMed ID: 22002157
[TBL] [Abstract][Full Text] [Related]
19. The role of the lymphatic system in vaccine trafficking and immune response.
Pal I; Ramsey JD
Adv Drug Deliv Rev; 2011 Sep; 63(10-11):909-22. PubMed ID: 21683103
[TBL] [Abstract][Full Text] [Related]
20. Biomaterials as vaccine adjuvants.
Jones KS
Biotechnol Prog; 2008; 24(4):807-14. PubMed ID: 19194892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
